[1]
Burri, E., Juillerat, P., Maillard, M.H., Manz, M., Michetti, P., Mottet, C., Rogler, G., Zahnd, N. and Vavricka, S. 2019. Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Medical Weekly. 149, 4950 (Dec. 2019), w20148. DOI:https://doi.org/10.4414/smw.2019.20148.